Latest
Research, clinical trials, regulatory updates, and industry analysis from the longevity medicine world.
This week's radar covers blood-based Alzheimer's biomarkers, FDA-cleared imaging AI, DXA/DEXA upgrades, wearable VO₂ estimates, and smarter questions for buyers.
A practical 2026 guide to biological age testing in longevity clinics: epigenetic clocks, proteomic and multi-omics clocks, imaging-derived organ age, inflammatory markers, and the clinical tests that actually change decisions.
Fountain Life is one of the clearest examples of premium diagnostic longevity medicine. Here is what the membership appears to cost, who it fits, and which alternatives to compare.
Epigenetic age tests are marketed as the ultimate longevity metric. But the same sample can produce a 15-year discrepancy, there are no clinical standards, and better diagnostics exist. Here's what the science actually says.
Fountain Life and Human Longevity Inc. both offer premium diagnostic assessments in the US, but differ on genomic depth, AI integration, pricing model, and geographic reach. A data-driven comparison.
Mayo Clinic and Cleveland Clinic both offer elite executive health programs with institutional credibility no startup can match. We compare their diagnostics, specialties, pricing, and how they fit into the longevity clinic landscape.